Alzheimer's disease: amyloid-based pathogenesis and potential therapies

被引：25
|
作者：
Zhou, Yixiu [1 ]
Sun, Yuhui [2 ,3 ]
Ma, Quan-Hong [2 ,3 ]
Liu, Yaobo [2 ,3 ]
机构：
[1] Soochow Univ, Med Coll, Suzhou 215004, Jiangsu, Peoples R China
[2] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China
[3] Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China
来源：
CELL STRESS | 2018年 / 2卷 / 07期
关键词：
Alzheimer's disease (AD); amyloid beta (A beta); synapses; neural circuits; treatment;
D O I：
10.15698/cst2018.07.143
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Alzheimer's disease is one of the most severe neurodegenerative diseases among elderly people. Different pathogenic factors for Alzheimer's disease have been posited and studied in recent decades, but no effective treatment has been found, necessitating further studies. In this Viewpoint article, we assess studies on the mechanisms underlying the accumulation of amyloid beta (A beta) peptide and the formation of A beta oligomers because their accumulation in amyloid plaques in brain tissue has become a well-studied hallmark of Alzheimer's disease. We focus on the production of A beta and its impact on the function of synapses and neural circuits, and also discuss the clinical prospects for amyloid-targeted therapies.
引用
收藏
页码：150 / 161
页数：12
相关论文
共 50 条
  • [31] Potential of anti-amyloid therapies for patients with Alzheimer disease in Canada
    Frank, Andrew
    Frank, Chris
    Molnar, Frank
    CANADIAN FAMILY PHYSICIAN, 2024, 70 (09) : 537 - 538
  • [32] Anti-amyloid antibody therapies in Alzheimer's disease
    Perneczky, Robert
    Jessen, Frank
    Grimmer, Timo
    Levin, Johannes
    Floeel, Agnes
    Peters, Oliver
    Froelich, Lutz
    BRAIN, 2023, 146 (03) : 842 - 849
  • [33] Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease
    Quenon, Lisa
    Dricot, Laurence
    Woodard, John L.
    Hanseeuw, Bernard
    Gilis, Nathalie
    Lhommel, Renaud
    Ivanoiu, Adrian
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2016, 22 (10) : 991 - 1004
  • [34] Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
    Pimplikar, Sanjay W.
    Nixon, Ralph A.
    Robakis, Nikolaos K.
    Shen, Jie
    Tsai, Li-Huei
    JOURNAL OF NEUROSCIENCE, 2010, 30 (45): : 14946 - 14954
  • [35] Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease
    Saido, Takaomi C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [36] Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
    Kirsten L. Viola
    William L. Klein
    Acta Neuropathologica, 2015, 129 : 183 - 206
  • [37] Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease
    Charles Glabe
    Journal of Molecular Neuroscience, 2001, 17 : 137 - 145
  • [38] The pathogenesis of Alzheimer's disease -: Is amyloid β-protein the beginning or the end?
    Yankner, BA
    ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 26 - 28
  • [39] Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
    Viola, Kirsten L.
    Klein, William L.
    ACTA NEUROPATHOLOGICA, 2015, 129 (02) : 183 - 206
  • [40] THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Szarka Andras
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (7-8): : 222 - 228
12345